Baxter Ventures
| Federal/State Opportunity Number | Not Applicable |
| Funding Opportunity Purpose | Created in 2011 by Baxter International Inc., Baxter Ventures builds on the company’s more than 85-year legacy of supporting healthcare innovation and saving and sustaining lives worldwide. Baxter Ventures’ investment focus includes therapeutic areas complementary to Baxter’s presence in critical, hospital, nutritional, renal and surgical care, as well as cutting-edge technology and therapies outside of Baxter’s current product portfolio. |
| Type of Funding Opportunity | Private |
| Florida Resident Specific Opportunity | No |
| Funding Mechanism | Equity Financing |
| Organization | Baxter International |
| Focus Area | All Innovation |
| Funding Size | Not Specified |
| Funding Post Date | Not Specified |
| Funding Closing Date | Not Specified |
| Funding Timelines | Not Specified |
| Funding Opportunity Cycle | Recurring |
| Eligible Recipients | Entrepreneurs |
| Non-For-Profit Funding Only | No |
| Small Business Funding Only | No |
| Early Stage Funding Only | No |
| Minority Ownership Required | No |
| US Ownership Required | Not Specified |
| Federal Cost Share Requirements | No |
| Contact Information | Email: Ventures@baxter.com |
| Website Link | https://www.baxter.com/our-story/fueling-collaborative-innovation/baxter-ventures |
| Additional Eligibility Criteria Notes | Baxter Ventures invests in companies with innovative technologies, products, and therapies that accelerate growth and advance patient care. Each investment opportunity undergoes a rigorous evaluation process to determine if it has the potential to address unmet clinical needs and offer sustainable long-term growth. Areas of Interest Include: In-Hospital Solutions and Therapeutics Critical Care Surgical Care Medical Devices Monitoring and Diagnostic Tools Medication Delivery and Management Pharmacy Technology Tools Renal Therapies Healthcare Information Technology |
| Additional Information Application Process | The following non-confidential information should be included and Baxter will respond if there is sufficient interest and alignment for investment. – Company name, primary contact name and contact information – Brief, non-confidential description or overview material |
| Important Reporting Requirements (If Specified) | Not Specified |
| Miscellaneous Notes | Not Identifiable |